Clinical Trial Update: Artificial Neural Network Directed Therapy of Severe Obstructive Sleep Apnea [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating artificial neural network directed therapy for severe obstructive sleep apnea has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Sleep Apnea | Phase 3 | Status: WITHDRAWN